{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T08:31:13Z","timestamp":1700209873065},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1983,5,1]],"date-time":"1983-05-01T00:00:00Z","timestamp":420595200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch. Pharmacol."],"published-print":{"date-parts":[[1983,5]]},"DOI":"10.1007\/bf00508341","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T04:11:32Z","timestamp":1100751092000},"page":"261-270","source":"Crossref","is-referenced-by-count":32,"title":["The effects of dose and duration of chronic pimozide adminstration on dopamine receptor supersensitivity"],"prefix":"10.1007","volume":"322","author":[{"given":"Kevin J.","family":"Dewey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. C.","family":"Fibiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1073\/pnas.72.11.4655","volume":"72","author":"DR Burt","year":"1975","unstructured":"Burt DR, Enna SJ, Creese I, Snyder SH (1975) Dopamine receptor binding in the corpus striatum of mammalian brain. Proc Natl Acad Sci USA 72:4655?4659","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR2","first-page":"800","volume":"12","author":"DR Burt","year":"1976","unstructured":"Burt DR, Creese, I, Snyder SH (1976) Properties of [3H]-haloperidol and [3H]-dopamine binding associated with dopamine receptors in calf brain membranes. Mol Pharmacol 12:800?812","journal-title":"Mol Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1126\/science.847477","volume":"196","author":"DR Burt","year":"1977","unstructured":"Burt DR, Creese I, Snyder S (1977) Anti-schizophrenic drugs ? chronic treatment elevates DA receptor binding in the brain. Science 196:326?328","journal-title":"Science"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0773.1963.tb01730.x","volume":"20","author":"A Carlsson","year":"1963","unstructured":"Carlsson A, Lindqvist (1963) Effect of chlorpromazine and haloperidol on formation of 3-methoxytryptamine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20:140?144","journal-title":"Acta Pharmacol Toxicol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00423298","volume":"48","author":"AV Christensen","year":"1976","unstructured":"Christensen AV, Fjalland B, Moller-Nielsen I (1976) On the supersensitivity of dopamine receptors induced by neuroleptics. Psychopharmacology 48:1?6","journal-title":"Psychopharmacology"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0014-2999(79)90499-0","volume":"57","author":"A Clow","year":"1979","unstructured":"Clow A, Jenner P, Marsden CD (1979) Changes in dopamine-mediated behavior during one year's neuroleptic administration. Eur J Pharmacol 57:365?375","journal-title":"Eur J Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(80)90438-0","volume":"63","author":"A Clow","year":"1980","unstructured":"Clow A, Theodoru A, Jenner P, Marsden CD (1980) Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration. Eur J Pharmacol 63:145?157","journal-title":"Eur J Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1176\/ajp.127.10.1407","volume":"127","author":"GE Crane","year":"1971","unstructured":"Crane GE (1971) Persistence of neurological symptoms due to neuroleptic drugs. Am J Psychiatry 127:1407?1410","journal-title":"Am J Psychiatry"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0006-8993(75)90834-3","volume":"83","author":"I Creese","year":"1975","unstructured":"Creese I, Iversen SD (1975) The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83:419?436","journal-title":"Brain Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/270180a0","volume":"270","author":"I Creese","year":"1977","unstructured":"Creese I, Snyder SH (1977) A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood. Nature 270:180?182","journal-title":"Nature"},{"key":"CR11","first-page":"170","volume":"38","author":"R Degkwitz","year":"1967","unstructured":"Degkwitz R, Binsack KF, Herbert H, Luxenburger O, Wenzel W (1967) Zum Probleme der persistierenden Hyperkinesen nach langfristiger Anwendung von Neuroleptika. Nervenarzt 38:170?174","journal-title":"Nervenarzt"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1440-1681.1977.tb02613.x","volume":"4","author":"R Dunstan","year":"1977","unstructured":"Dunstan R, Jackson DM (1977) The effects of apomorphine and clonidine on locomotor activity in mice after long term treatment with haloperidol. Clin Exp Pharmacol Physiol 4:131?141","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF00403900","volume":"10","author":"AM Ernst","year":"1967","unstructured":"Ernst AM (1967) Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacology 10:316?324","journal-title":"Psychopharmacology"},{"key":"CR14","first-page":"303","volume":"11","author":"K Fuxe","year":"1976","unstructured":"Fuxe K, Ungerstedt U (1976) Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 11:303?314","journal-title":"Eur J Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00421217","volume":"34","author":"J Gerlach","year":"1974","unstructured":"Gerlach J, Reisby N, Randrup A (1974) Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacology 34:21?35","journal-title":"Psychopharmacology"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0024-3205(74)90078-2","volume":"14","author":"G Gianutsos","year":"1974","unstructured":"Gianutsos G, Drawbaugh RB, Hynes MD, Lal H (1974) Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol. Life Sci 14:887?894","journal-title":"Life Sci"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00426838","volume":"50","author":"LM Gunne","year":"1976","unstructured":"Gunne LM, Barany S (1976) Haloperidol-induced tardive dyskinesia in monkeys. Psychopharmacology 50:237?240","journal-title":"Psychopharmacology"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0006-2952(76)90348-8","volume":"25","author":"JC Holmes","year":"1976","unstructured":"Holmes JC, Rutledge CO (1976) Effects of the d- and h-isomers of amphetamine on uptake release and catabolism of norepinephrine dopamine and 5-hydroxytryptamine in several regions of rat brain. Biochem Pharmacol 25:447?451","journal-title":"Biochem Pharmacol"},{"key":"CR19","first-page":"758","volume":"57","author":"R Hunter","year":"1964","unstructured":"Hunter R, Earl CJ, Thornicroft S (1964) An apparently irreversible syndrome of abnormal movements following phenothiazine medication. Proc R Soc Med 57:758?762","journal-title":"Proc R Soc Med"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.1979.tb05208.x","volume":"33","author":"J Hyttel","year":"1979","unstructured":"Hyttel J (1979) Neurochemical parameters in the hyperresponsive phase after a single dose of neuroleptics to mice. J Neurochem 33:641?646","journal-title":"J Neurochem"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00429053","volume":"45","author":"DM Jackson","year":"1975","unstructured":"Jackson DM, Anden NE, Engel J, Liljequist S (1975) The effect of long term penfluridol treatment on the sensitivity of dopamine receptors in the nucleus accumbens and in the corpus striatum. Psychopharmacology 45:151?155","journal-title":"Psychopharmacology"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.131.8.910","volume":"131","author":"G Jacobsen","year":"1974","unstructured":"Jacobsen G, Baldessarini RJ, Manschreck T (1974) Tardive and with-drawal dyskinesia associated with haloperidol. Am J Psychiatry 131:910?913","journal-title":"Am J Psychiatry"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00431827","volume":"72","author":"RS Kamer","year":"1981","unstructured":"Kamer RS, Turi AR, Solomon PR, Kaplan LJ (1981) Increased mesolimbic dopamine binding following chronic haloperidol treatment. Psychopharmacology 72:261?263","journal-title":"Psychopharmacology"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archpsyc.1972.01750250081011","volume":"27","author":"H Kazamatsuri","year":"1972","unstructured":"Kazamatsuri H, Chien C, Cole JO (1972) Treatment of tardive dyskinesia. Arch Gen Psych 27:95?103","journal-title":"Arch Gen Psych"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF01245320","volume":"33","author":"HL Klawans","year":"1972","unstructured":"Klawans HL, Rubovits H (1972) An experimental model of tardive dyskinesia. J Neural Trans 33:235?246","journal-title":"J Neural Trans"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/ajp.130.1.82","volume":"130","author":"HL Klawans","year":"1973","unstructured":"Klawans HL (1973) The pharmacology of tardive dyskinesia. Am J Psychiatry 130:82?86","journal-title":"Am J Psychiatry"},{"key":"CR27","first-page":"405","volume-title":"Animal models in psychiatry and neurology","author":"RM Kobayashi","year":"1978","unstructured":"Kobayashi RM, Fields JZ, Hruska RE, Beaumont K, Yamamura HI (1978) Brain neurotransmitter receptors and chronic antipsychotic drug treatment: A model for tardive dyskinesia. In: Hanin I, Usdin E (eds) Animal models in psychiatry and neurology. Pergamon Press Ltd, New York, pp 405?410"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/287052a0","volume":"287","author":"MR Koslowski","year":"1980","unstructured":"Koslowski MR, Sawyer S, Marshall JF (1980) Behavioral effects and supersensitivity following nigral dopamine receptor stimulation. Nature 287:52?54","journal-title":"Nature"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0006-8993(77)90806-X","volume":"136","author":"MP Martres","year":"1977","unstructured":"Martres MP, Costentin J, Bandry M, Marcais H, Protais P, Schwartz JC (1977) Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioral and biochemical studies. Brain Res 136:319?337","journal-title":"Brain Res"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00433805","volume":"72","author":"WT McKinney","year":"1980","unstructured":"McKinney WT, Moran EC, Kraemer GW, Prange Jr AJ (1980) Longterm chlorpromazine in rhesus monkeys: Production of dyskinesias and changes in social behavior. Psychophamacology 72:35?39","journal-title":"Psychophamacology"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00421933","volume":"34","author":"I Moller-Nielsen","year":"1974","unstructured":"Moller-Nielsen I, Fjallano B, Pedersen V, Nymack M (1974) Pharmacology of neuroleptics upon repeated administration. Psychopharmacology 34:95?104","journal-title":"Psychopharmacology"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/0024-3205(77)90155-2","volume":"21","author":"P Muller","year":"1977","unstructured":"Muller P, Seeman P (1977) Brain neurotransmitter receptors after long term haloperidol: Dopamine acetylcholine, serotonin ?-noradrenergic and naloxone receptors. Life Sci 21:1751?1758","journal-title":"Life Sci"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00429171","volume":"60","author":"P Muller","year":"1978","unstructured":"Muller P, Seeman P (1978) Dopaminergic supersensitivity after neuroleptics: Time course and specificity. Psychophamacology 60:1?11","journal-title":"Psychophamacology"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0014-2999(74)90023-5","volume":"29","author":"MTC Price","year":"1974","unstructured":"Price MTC, Fibiger HC (1974) Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra. Eur J Pharmacol 29:249?252","journal-title":"Eur J Pharmacol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0024-3205(81)90027-8","volume":"29","author":"RB Rastogi","year":"1981","unstructured":"Rastogi RB, Singhal RL, Lapierre YD (1981) Effects of short- and long-term neuroleptic treatment on brain serotonin synthesis and turnover: Focus on the serotonin hypothesis of schizophrenia. Life Sci 29:735?741","journal-title":"Life Sci"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0003-2697(67)90297-7","volume":"20","author":"HE Rosenthal","year":"1967","unstructured":"Rosenthal HE (1967) A graphic method for the determination and presentation of binding parameters in a complex system. Anal Biochem 20:525?532","journal-title":"Anal Biochem"},{"key":"CR37","first-page":"429","volume":"3","author":"RH Roth","year":"1979","unstructured":"Roth RH (1979) Dopamine autoreceptors: Pharmacology, function and comparison with post-synaptic dopamine receptors. Comm Psychopharmacol 3:429?445","journal-title":"Comm Psychopharmacol"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-2999(76)90019-4","volume":"37","author":"BJ Sahakian","year":"1976","unstructured":"Sahakian BJ, Robbins TL, Iversen SD (1976) ?-Flupenthixol-induced hyperactivity by chronic dosing in rats. Eur J Pharmacol 37:169","journal-title":"Eur J Pharmacol"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00421063","volume":"41","author":"AC Sayers","year":"1975","unstructured":"Sayers AC, Burki HR, Ruch W, Asper H (1975) Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesia. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Psychopharmacology 41:97?104","journal-title":"Psychopharmacology"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1749-6632.1949.tb27297.x","volume":"51","author":"G Scatchard","year":"1949","unstructured":"Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660?672","journal-title":"Ann NY Acad Sci"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/2141210a0","volume":"214","author":"EL Schelkunov","year":"1967","unstructured":"Schelkunov EL (1967) Adrenergic effect of chronic administration of neuroleptics. Nature 214:1210?1213","journal-title":"Nature"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archneur.1966.00470100025003","volume":"14","author":"WR Schmidt","year":"1966","unstructured":"Schmidt WR, Jarcho LW (1966) Persistent dyskinesia following phenothiazine therapy. Arch Neurol 14:369?377","journal-title":"Arch Neurol"},{"key":"CR43","first-page":"131","volume-title":"Advances in neurology, vol 9","author":"G Sedvall","year":"1975","unstructured":"Sedvall G, Fyro B, Nyback H, Wiesel FA (1975) Actions of dopaminergic antagonists in the striatum. In: Calne DB, Chase TN, Barbeau A (eds) Advances in neurology, vol 9. Raven Press, New York, pp 131?140"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0024-3205(76)90170-3","volume":"19","author":"RC Smith","year":"1976","unstructured":"Smith RC, Davis JM (1976) Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine and thioridazine. Life Sci 19:725?732","journal-title":"Life Sci"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0006-8993(81)90704-6","volume":"211","author":"DA Staunton","year":"1981","unstructured":"Staunton DA, Wolfe BB, Groves PM, Molinoff PB (1981) Dopamine receptor changes following destruction of the nigrostriatal pathway: Lack of a relationship to rotational behavior. Brain Res 211: 315?327","journal-title":"Brain Res"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0028-3908(74)90084-7","volume":"13","author":"D Tarsy","year":"1974","unstructured":"Tarsy D, Baldessarini RJ (1974) Behavioral supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacology 13:927?940","journal-title":"Neuropharmacology"},{"key":"CR47","first-page":"307","volume":"16","author":"JE Thornburg","year":"1974","unstructured":"Thornburg JE, Moore KE (1974) Supersensitivity to dopaminergic agonists following withdrawal of a chronic diet containing haloperidol or pimozide. Pharmacologist 16:307","journal-title":"Pharmacologist"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0364-7722(77)90053-4","volume":"1","author":"K Voith","year":"1977","unstructured":"Voith K (1977) Comparison of behavioral supersensitivity to apomorphine after fluphenazine dihydrochloride and fluphenazine decandate treatment in rats. Prog Neuro Psychopharmacol 1:289?295","journal-title":"Prog Neuro Psychopharmacol"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00492366","volume":"53","author":"B Weiss","year":"1977","unstructured":"Weiss B, Santelli S, Lusink K (1977) Movement disorders induced in monkeys by chronic haloperidol treatment. Psychopharmacology 53:289","journal-title":"Psychopharmacology"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0014-2999(75)90062-X","volume":"31","author":"GG Yarbrough","year":"1975","unstructured":"Yarbrough GG (1975) Supersensitivity of caudate neurones after repeated administration of haloperidol. Eur J Pharmacol 31: 367?369","journal-title":"Eur J Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00508341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00508341\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00508341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T14:17:00Z","timestamp":1554387420000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00508341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,5]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1983,5]]}},"alternative-id":["BF00508341"],"URL":"https:\/\/doi.org\/10.1007\/bf00508341","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,5]]}}}